TC BioPharm Moves Forward with ACHIEVE Phase 2b Clinical Trial: Final Dosing Completed for Three PatientsBusiness PenDecember 20, 2024 December 20, 2024 TC BioPharm (Holdings) PLC (NASDAQ: TCBP), a clinical-stage biotechnology company specializing in allogeneic gamma-delta T cell therapies, has made notable progress in its ACHIEVE Phase...
